Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study

被引：0
|
作者：
Bateman, Eric [1 ]
Ferguson, Gary T. [2 ]
Barnes, Neil [3 ]
Gallagher, Nicola [4 ]
Green, Yulia [4 ]
Horton, Rachael [4 ]
Henley, Michelle [4 ]
Banerji, Donald [5 ]
机构：
[1] Univ Cape Town, Dept Med, Rondebosch, South Africa
[2] Pulm Res Inst Southeast Michigan, Pulm Dept, Livonia, MI USA
[3] Barts Hlth NHS Trust, London Chest Hosp, London, England
[4] Novartis Horsham Res Ctr, Resp Dept, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Resp Dept, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
COPD; -; management; Bronchodilators;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
7248
引用
收藏
页数：2
相关论文
共 50 条
  • [21] QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease
    van Noord, Jan A.
    Buhl, Roland
    LaForce, Craig
    Martin, Carmen
    Jones, Francis
    Dolker, Michael
    Overend, Tim
    THORAX, 2010, 65 (12) : 1086 - 1091
  • [22] SUSTAINED 24-HOUR BRONCHODILATION WITH NVA237 ONCE-DAILY IN PATIENTS WITH COPD: THE GLOW1 TRIAL
    Kato, M.
    Urzo, Ad'
    Martin, C.
    Banerji, D.
    Lu, Y.
    Overend, T.
    RESPIROLOGY, 2011, 16 : 106 - 106
  • [23] Once-Daily Qva149 Improves Symptom Scores In Patients With COPD
    Welte, T.
    Dahl, R.
    Chen, H.
    Gallagher, N.
    D'Andrea, P.
    Alagappan, V.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [24] ONCE-DAILY QVA149 PROVIDES SUPERIOR BRONCHODILATION AND IMPROVES LUNG FUNCTION VERSUS TWICE-DAILY FLUTICASONE/SALMETEROL IN COPD PATIENTS: THE ILLUMINATE STUDY
    Vogelmeier, C.
    Bateman, E.
    Pallante, J.
    Bryant, H.
    Alagappan, V.
    D'Andrea, P.
    He, E.
    Banerji, D.
    THORAX, 2012, 67 : A149 - A149
  • [25] Efficacy Of Once-Daily Qva149 Compared With Tiotropium Plus Theophylline In Symptomatic Patients With Moderate To Severe COPD
    Kirishi, S.
    Kubo, A.
    Okabayashi, A.
    Akaba, T.
    Takeyama, K.
    Tagaya, E.
    Kondo, M.
    Tamaoki, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] Dual Bronchodilation With Once-Daily Qva149 Significantly Improves Lung Function Versus Single Bronchodilators And Salmeterol/fluticasone
    Bateman, E. D.
    Ferguson, G. T.
    Welte, T.
    D'Andrea, P.
    Alagappan, V.
    Chen, H.
    Green, Y.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] DUAL BRONCHODILATION WITH QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: IGNITE TRIALS OVERVIEW
    Mezzi, Karen
    Fedele, Mark J.
    Chen, Hungta
    Banerji, Donald
    RESPIROLOGY, 2013, 18 : 69 - 69
  • [28] Once-daily QVA149 has a good safety profile in patients with COPD
    Welte, Tobias
    Vogelmeier, Claus
    Dahl, Ronald
    Chapman, Kenneth R.
    Rudolf, Michael
    Mehta, Rajendra
    D'Andrea, Peter
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In A Subgroup Of Patients With Severe COPD: The Spark Study
    Wedzicha, J.
    D'Urzo, A. D.
    Decramer, M.
    Ficker, J. H.
    Sandstrom, T.
    Taylor, A. Fowler
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Banerji, D.
    Fogel, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [30] Superior Lung Function With Once-Daily Qva149 Translates Into Improvements In Patient-Reported Breathlessness Compared With Placebo And Tiotropium In COPD Patients: The Blaze Study
    Mahler, D. A.
    Decramer, M.
    D'Urzo, A. D.
    Worth, H.
    White, T.
    Alagappan, V.
    Gallagher, N.
    Chen, H.
    Kulich, K.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345